Excellence in Collaboration
The challenge of discovering and developing medicines for unmet needs is too great for any single organization. Knopp’s corporate priorities include excellence in collaboration, including our relationships with technical vendors and professional advisors, whom we consider keys to our success. Following are some of our key partners.
Knopp has secured the financing necessary to achieve significant milestones in the development of its assets. Our funding partners include Saturn Capital and Saturn Partners II of Boston; Kramer Capital Partners of Stamford, CT; LaunchCyte LLC and Innovation Works of Pittsburgh, PA; and a number of private partnerships that recognize the investment potential of addressing unmet needs in rare diseases.
Albany Molecular Research, Inc.
Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For over 21 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides AMRI customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development.
Founded in 2002, QS Pharma provides a broad range of contract development/research and clinical/commercial manufacturing services for pharmaceutical and biopharmaceutical companies worldwide. The business is founded on the tenet of Quality with Speed and is based on the extensive expertise and knowledge in the area of pharmaceutical product development.
Preclinical Development Partner
MPI Research is a privately held midwestern company that focuses on the nonclinical research needs of the pharmaceutical, biotech, chemical, agricultural, and related industries. MPI's success is attributed to the mastery of effective teamwork and to being the very best in its field.
Clinical Trials Resource
Northeast Amyotrophic Lateral Sclerosis Consortium
The mission of the Northeast Amyotrophic Lateral Sclerosis Consortium (NEALS) is to translate research advances rapidly into clinical trials for patients with ALS. NEALS was established in 1995 by investigators from nine northeast region academic institutions sharing a special interest in ALS. Since then, the NEALS Consortium has welcomed investigators from throughout the North America, and now comprises 70 ALS clinics and research centers from coast to coast. NEALS is co-chaired by Merit Cudkowicz, M.D., Associate Professor of Neurology at Massachusetts General Hospital, at Harvard Medical School, and Jeremy Shefner, M.D., Ph.D., Professor and Chair of Neurology at Upstate Medical University in Syracuse, New York.
Corporate and Licensing Counsel
Kirkpatrick & Lockhart Preston Gates Ellis LLP (K&L Gates) comprises approximately 1,400 lawyers who practice in offices located in the U.S., China, France, Britain, and Taiwan. K&L Gates represents capital markets participants and leading global corporations, growth and middle-market companies, and entrepreneurs in every major industry group, as well as public sector entities.
Intellectual Property Counsel
Pepper Hamilton LLP
Pepper Hamilton LLP is a multi-practice law firm with 450 lawyers in seven states and the District of Columbia. The firm provides corporate, litigation, intellectual property, and regulatory legal services to leading businesses, governmental entities, nonprofit organizations, and individuals throughout the nation and the world.